Abstract

Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that acts primarily on endothelial cells, but numerous studies suggest that VEGF also acts on non-endothelial cells, including trophoblast cells. Inhibition of VEGF signaling by excess production of the endogenous soluble VEGF receptor sFlt1 in trophoblast cells has been implicated in several pregnancy complications. Our previous studies and other reports have shown that VEGF directly regulates placental vascular development and functions and that excess VEGF production adversely affects placental vascular development. Trophoblast giant cells (TGCs) line the maternal side of the placental vasculature in mice and function like endothelial cells. In this study, we specifically examined the effect of excess VEGF signaling on TGC development associated with defective placental vascular development using two mouse models an endometrial VEGF overexpression model and a placenta-specific sFlt1 knockdown model. Placentas of endometrial VEGF-overexpressing dams at embryonic days (E) 11.5 and 14.5 showed dramatic enlargement of the venous maternal spaces in junctional zones. The size and number of the parietal TGCs that line these venous spaces in the placenta were also significantly increased. Although junctional zone venous blood spaces from control and VEGF-overexpressing dams were not markedly different in size at E17.5, the number and size of P-TGCs were both significantly increased in the placentas from VEGF-overexpressing dams. In sFlt1 knockdown placentas, however, there was a significant increase in the size of the sinusoidal TGC-lined, alkaline phosphatase-positive maternal blood spaces in the labyrinth. These results suggest that VEGF signaling plays an important role in maintaining the homeostasis of the maternal vascular space in the mouse placenta through modulation of TGC development and differentiation, similar to the effect of VEGF on endothelial cells in other vascular beds.

Highlights

  • We examined the specific effects of increased Vascular endothelial growth factor (VEGF) signaling on trophoblast giant cells (TGCs) development and differentiation using our previously developed endometrial VEGF overexpression and placenta-specific Soluble Flt1 (sFlt1) knockdown models [9]

  • We previously reported the development of mouse models for endometrial overexpression of VEGF and placenta-specific knockdown of sFlt1 [9]

  • This study has provided new insights into the role of VEGF signaling in maintenance of the homeostasis of the placental maternal vascular space through modulation of TGC development and differentiation

Read more

Summary

Introduction

Vascular endothelial growth factor (VEGF) is an angiogenic factor widely studied for its critical and highly dose-sensitive role in embryonic vascular development. VEGF primarily targets endothelial cells [1,2,3], it can target various non-endothelial cells, including placental trophoblasts, which have endothelial cell characteristics [4,5]. Unlike the vascular spaces of other tissues, the maternal blood spaces in the placenta are not lined by endothelial cells, but rather by a variety of specialized trophoblast cells that, in mice, are called trophoblast giant cells (TGCs) [5,6,7]. Previous studies have identified multiple subtypes of TGC based on morphological and molecular characteristics [5,6,7,8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call